A widely available antiviral medication offers new possibilities for long Covid patients seeking relief from debilitating ...

A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...

A Wall Street maxim states, “Twenty percent of investors who want to make money are in stocks, while the other 80 percent who ...

Scientists are currently studying how well people are protected against severe disease from XFG. Researchers conducted lab ...

PFE trades above its 50-day average for over a month, signaling bullish momentum despite COVID revenue declines and patent ...

An extremely painful sore throat, often now referred to as “razor blade throat”, is just one of the several symptoms of a new ...

Symptoms mirror Omicron’s, that is, fever, cough, fatigue, sore throat, and muscle aches. Though India’s Covid response ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

Encounter-level factors played a key role in limiting outpatient COVID-19 treatment for Black and Latino patients.

Three supercharged dividend stocks have the necessary catalysts to make their patient shareholders notably richer.

More than 5 years after the pandemic's start, COVID remains a public health challenge. From October 2024 to April 2025, the ...